Previous slide
Next slide
paediatricms

Early High-Efficacy Therapy in Paediatric MS Reduces Risk of Reaching Key Disability Milestones

New study reveals early highly effective therapy significantly reduces disability...
network-web

How the Big MS Data network is advancing MS research

The Big MS Data network consists of multiple national and...
tessa-may-50k

Tessa, The May 50K Motivator

Let us introduce you to Tessa, one of the incredible...
Rohan Greenland The May 50K

From our CEO

CEO Rohan Greenland shares insights into the world-class, life-changing MS...
over-60s-image

Ocrelizumab effectively reduces MS relapses in over 60s

Real-world evidence confirms the benefits of starting treatment in people...
feature-rachel-kerr

Award for providing a voice to people living with MS in the Queensland community

MS Australia has today announced Ms Rachel Kerr as the...

Our vision

A world without MS

Read More

Newsletter subscription

  • Enter your details

Home